Probability of axillary lymph node metastasis in early breast cancer patien - Evidencio
Probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound
This model includes ultrasound parameters to predict the probability of ALN metastasis in early breast cancer patients.
The model needs to be further validated before applying into clinical practice.
Research authors: Si-Qi Qiu, Huan-Cheng Zeng, Fan Zhang, Cong Chen, Wen-He Huang, Rick G Pleijhuis, Jun-Dong Wu, Gooitzen M van Dam, Guo-Jun Zhang.
Version: 1.59.{{ model.microversion }}
  • Public
  • Oncology
  • {{ modelType }}
  • Algorithm
  • Details
  • Validate
  • Save input
  • Load input

  • {{ toolbarErrorMessage }}

Display
Units

{{ section.title }}

{{ section.description }}

Calculate the result

Set more parameters to perform the calculation

Predicted probability of axillary metastasis:

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Result interval {{ additionalResult.min }} to {{ additionalResult.max }}

Conditional information

Your text input(s) have been changed. Please update your result. Update

Model performance
In the modeling group (N=322), lymph node metastasis was detected in 163 (50.6%) patients. The model was well calibrated in the modeling group. Especially in the low predictive-probability subgroups, the model was found to provide a promising predictive value in early breast cancer patients. Hosmer-Lemeshow goodness-of-fit test indicated a good overall fit of the model (P-value: 0.18).

Validation:
The model developers performed an external validation on a separate cohort consisting of 234 patients. The calculated area under the ROC curve (c-index) for the validation group was 0.864, indicating good discriminative power of the model.

Predictors included in the model:
Tumor size and histological grade have been reported to be risk factors for ALN metastasis in many other studies (references included in original research paper). The current study confirmed these results. The predictive value of ER and PR status was uncertain in previous studies, with some studies showing no predictive value for ER and PR status and others reporting that lower risk of ALN metastasis was found in tumors with negative expression of either ER or PR. In the current study, ER overexpression was found to be associated with higher probability of ALN metastasis. This finding may be counterintuitive, but it was similar to the findings from Bevilacqua et al (2007). Although the reason of this phenomenon is unknown, it is hypothesized that ER negative tumors prefer hematogenous metastasis rather than lymphatic metastasis.

Model limitations:
Although the model showed good stability in the underlying study, it needs to be validated in more external validation groups to further evaluate its predictive ability.
Second, risk factors like clinical tumor size, cortical thickness and transverse diameter of lymph node may differ when measured by different doctors.

Source:
Qiu SQ, Zeng HC, Zhang F, et al. A nomogram to predict the probability of axillary lymph node metastasis in early breast cancer patients with positive axillary ultrasound. Sci Rep. 2016;6:21196.

{{ file.classification }}
PRO
Note
Notes are only visible in the result download and will not be saved by Evidencio

This algorithm is provided for educational, training and information purposes. It must not be used to support medical decision making, or to provide medical or diagnostic services. Read our full disclaimer.

Underlying algorithms Part of
Comments
Comment
Please enter a comment
Comments are visible to anyone

Algorithm feedback

No feedback yet 1 Comment {{ model.comments.length }} Comments
On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote:
{{ comment.content }}
logo

Please sign in to enable Evidencio print features

In order to use the Evidencio print features, you need to be logged in.
If you don't have an Evidencio Community Account you can create your free personal account at:

https://www.evidencio.com/registration

Printed results - Examples {{ new Date().toLocaleString() }}

Evidencio Community Account Benefits

With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.

Disclaimer: Calculations alone should never dictate patient care, and are no substitute for professional judgement.
Terms & Conditions Privacy Policy Disclaimer Contact Refuse cookies
Evidencio v3.40 © 2015 - 2026 Evidencio. All Rights Reserved